1001907-23-8 Usage
General Description
Tert-butyl 5-iodo-1H-indazole-1-carboxylate is a chemical compound with the formula C13H17IN2O2. It is a derivative of the indazole class of compounds, which are commonly used in pharmaceutical research and organic synthesis. This specific compound contains a tert-butyl group, an iodo substituent, and a carboxylate functional group, all of which contribute to its reactivity and properties. Tert-butyl 5-iodo-1H-indazole-1-carboxylate may be utilized as a building block in the synthesis of various biologically active molecules or as a starting material for further chemical transformations. Its specific applications may vary depending on the specific research or industrial context in which it is used.
Check Digit Verification of cas no
The CAS Registry Mumber 1001907-23-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,9,0 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1001907-23:
(9*1)+(8*0)+(7*0)+(6*1)+(5*9)+(4*0)+(3*7)+(2*2)+(1*3)=88
88 % 10 = 8
So 1001907-23-8 is a valid CAS Registry Number.
1001907-23-8Relevant articles and documents
5-HETEROARYL SUBSTITUTED INDAZOLES AS KINASE INHIBITORS
-
, (2009/01/24)
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A, R1, R2, R3 and m, are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as Glycogen Synthase kinase 3 (GSK-3), Rho kinase (ROCK), Janus Kinases (JAK), AKT, PAK4, PLK, CK2, KDR, MK2, JNK1, aurora, pim 1 and nek 2.
P38 inhibitors and methods of use thereof
-
Page/Page column 24; sheet 20, (2008/06/13)
This invention relates to inhibitors of p38, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders mediated by p38.
